Metethoheptazine
Appearance
![]() | |
![]() | |
Clinical data | |
---|---|
Other names | WY-535 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.392 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]
Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
[edit]- ^ GB 843924, "Substituted azacycloheptanes", assigned to American Home Products
- ^ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH (February 1965). "Metabolism of the Non-Narcotic Analgesic, WY-5355". Biochemical Pharmacology. 14 (2): 121–8. doi:10.1016/0006-2952(65)90067-5. PMID 14332457.
- ^ "Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice. Retrieved 8 October 2018.